USPTO serial 87208675
NEUROGENX INNOVATIVE NEUROGENIC SOLUTIONS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 30, 2017
- Examiner
- JENKINS, KEISHA MONIQUE HARD
- Law office
- TMO LAW OFFICE 112
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with NEUROGENX INNOVATIVE NEUROGENIC SOLUTIONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Lansing, MI, US
Lansing, MI, US
Lansing, MI, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Vincent S. Egolf
Vincent S. Egolf CORNER COUNSEL, LLC28 VALLEY ROADMONTCLAIR, NJ 07042UNITED STATESGoods and services
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neurogenx, Inc.
- Other trademarks owned by Neurogenx, Inc.
- Other trademarks owned by Neurogenx, Inc.
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named NEUROGENX INNOVATIVE NEUROGENIC SOLUTIONS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 30, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| May 10, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| May 10, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| May 10, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 8, 2023 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 30, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 8, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 8, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Mar 8, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 8, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 30, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 14, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 14, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 22, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 3, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 31, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 31, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 31, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 31, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 29, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2016 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 25, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 22, 2016 | NWAP | NEW APPLICATION ENTERED | — |